Indoco Remedies Ltd gets Form 483 with 4 observations for Plants 2 and 3 at Goa

The United States Food and Drug Administration (USFDA) has conducted GMP inspection of Indoco Remedies Limited's Plant II (Sterile Facility) and Plant III (OSD Facility) at Goa. The inspection was conducted from 20th February, 2023 to 28th February, 2023.

The USFDA has issued Form 483 with four (4) observations, which will be addressed within stipulated time. We believe that this will not have an impact on the supplies and the existing revenues from these Facilities.

The Company is committed to maintain compliances across all the facilities with cGMP quality standards at all times.

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 359.35 as compared to the previous close of Rs. 348.90. The total number of shares traded during the day was 31486 in over 1437 trades.

The stock hit an intraday high of Rs. 369.80 and intraday low of 355.85. The net turnover during the day was Rs. 11383698.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 Pharmaceuticals Form483 4Observations Goa Plant2 Plant3 SterileFacility OSDFacility